2016-03-03T00:00:00.000-05:00
debilitating genetic diseases,-0.61151
clinical-stage biopharmaceutical company,0.292876
FY2016 earnings,0.458816
strong buy rating,0.407203
price target,0.420616
consensus price target,0.438801
stock,0.0847878
Pharmaceutical Inc Daily,0.385693
InvestorPlace Broker Center,0.555736
biopharmaceutical company,0.292876
research report,0.365074
12-month high,-0.548806
Zacks Investment Research,0.343468
personal trading style,0.598412
average rating,-0.270142
research offerings,0.40995
Stifel Nicolaus,0.327718
average price,-0.266181
JPMorgan Chase,0.278876
consensus estimate,0.00636142
shares,0.079178
concise daily summary,0.502738
previous forecast,-0.265009
stock broker,0.245696
mid-day trading,-0.388229
Ultragenyx Pharmaceutical,0.0592944
